Form D · Venture Capital Fund
BIOLOGIX PARTNERS, LP
San Jose, CA · CIK 0001636129
Offering snapshot reported Jun 28, 2017 · SEC filing
- Reported sold
- $4.4M Indefinite offering
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 2, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 25
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 28, 2017 | Amendment | $4,400,000 | No comparison | 25 | SEC filing |
| Mar 10, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-235563
Source: Form D, filed Jun 28, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| General Partner Biologix Associates, Llc | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
2051 Ringwood Avenue
San Jose, CA, 95131
San Jose, CA, 95131